Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
WVE
WVE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
WVE News
Wave Life Sciences Shares Plunge 49.59% After Disappointing Data
3d ago
Fool
WAVE LIFE SCIENCES LTD: WEDBUSH REDUCES TARGET PRICE FROM $35 TO $15
3d ago
moomoo
Wave Life Sciences Shares Plunge Nearly 50% After Disappointing Data
3d ago
NASDAQ.COM
Wave Life and Golar LNG See Active Options Trading
3d ago
NASDAQ.COM
Wave Life Sciences Shares Plunge Nearly 50% on Trial Data Disappointment
3d ago
seekingalpha
WVE-007 Trial Data Triggers Stock Volatility
3d ago
stocktwits
Johnson Fistel Investigates Wave Life Sciences for Potential Investor Claims
4d ago
Globenewswire
Wave Life Sciences' Obesity Drug Data Disappoints Investors
4d ago
stocktwits
Wave Life Sciences Shares Plunge 57% on WVE-007 Trial Data
4d ago
seekingalpha
WVE-007 Clinical Trial Data Shows Significant Improvements
4d ago
Newsfilter
WAVE Life Sciences Ltd to Launch Phase 2A INLIGHT and New WVE-007 Trials as Incretin Add-On in 2026
4d ago
moomoo
FDA Rejects Multiple Experimental Drug Applications, Raising Investor Concerns
Mar 06 2026
CNBC
FDA Drug Approval Uncertainty Intensifies
Mar 06 2026
Newsfilter
Wave Life Sciences Q4 2025 Earnings Call Insights
Feb 26 2026
seekingalpha
Wave Life Sciences Reports 2025 Financial Results and Pipeline Progress
Feb 26 2026
NASDAQ.COM
Wave Life Sciences Q4 Earnings Report Analysis
Feb 26 2026
seekingalpha
Show More News
